Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines

Journal of Cosmetic and Laser Therapy

Volumn 12, Issue 2, 2010, Pages 106-111

  Lowe, Nicholas J ^a,b,c   Shah, Aadarsh ^a,b   Lowe, Philippa L ^a,b   Patnaik, Rickie ^b,c  

^a Cranley Clinic   (United Kingdom)

^b Clinical Research Specialists Inc   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botox; Botulinum toxins A; BTX A; Dysport; Efficacy; Facial line assay; Safety

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FACE; FEMALE; HEADACHE; HUMAN; INFLUENZA; MUSCLE CONTRACTION; MUSCLE TWITCH; PHOTOGRAPHY; PRIORITY JOURNAL; PTOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN BRUISING; WRINKLE;

ADULT; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FACIAL MUSCLES; FEMALE; FOREHEAD; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; REJUVENATION; SKIN AGING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949883132     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764170903480013     Document Type: Article

References (17)

1. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12: 924-927
2. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980; 87:1044-1049
3. Keen M, Blitzer A, Aviv J, Binder W, Prystowsky J, Smith H, et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double blind, placebo controlled study. Plast Reconstr Surg. 1994;94:94-99
4. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol. 1996;35:569-572
5. Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, et al. Botox Glabellar Lines I Study Group: A mul-ticenter, double-blind, randomized, placebo-controlled study of the effi cacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002; 46:840-849
6. Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and effi cacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg. 2005;31:257-262
7. Flynn TC, Carruthers JA, Carruthers JA, Clark RE 2nd. Botulinum A toxin (BOTOX) in the lower eyelid: Dose-fi nding study. Dermatol Surg. 2003;29:943-950
8. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Moore D. Botulinum toxins types A and B for brow furrows: Preliminary experiences with type B toxin dosing. J Cosmet Laser Ther. 2002;4:15-18.
9. Heckmann M, Plewig G, Hyperhidrosis Study Group. Low-dose effi cacy of botulinum toxin A for axillary hyperhidrosis: A randomized, side-by-side, open-label study. Arch Dermatol. 2005;141:1255-1259
10. Wohlfarth K, Goschel H, Frevert J, Dengler R, Bigalke H. Botulinum A toxins: Units versus units. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:335-340
11. Durif F. Clinical bioequivalence of the current commercial preparations of botulinum toxin. Eur J Neurol. 1995;2:17-18.
12. Sampaio C, Costa J, Ferreira JJ. Clinical comparability of marketed formulations of botulinum toxin. Mov Disord. 2004;19:129-136
13. Lowe P, Patnaik R, Lowe N. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: A double-blind, randomized study. J Am Acad Dermatol. 2006;55:975-980
14. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol. 2002;47:834-840
15. Trindade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007;33:37-43.
16. Cliff SH, Judodihardjo H, Eltringham E. Different formulations of botulinum toxin type A have different migration characteristics: A double-blind, randomized study. J Cosmet Dermatol. 2008;7:50-54
17. Carruthers A, Carruthers J, Hardas B, Kaur M, Goertelmeyer R, Jones D, et al. A validated grading scale for crow's feet. Dermatol Surg. 2008;34(suppl 2):S173-8.